AIHTA - Publications - Search - Atezolizumab (Tecentriq®) as monotherapy for the first-line treatment of advanced NSCLC

Rothschedl, E. and Grössmann, N. : Atezolizumab (Tecentriq®) as monotherapy for the first-line treatment of advanced NSCLC. Fact Sheet Nr. 190.

[thumbnail of Fact Sheet Nr.190.pdf]
Preview
 PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
320kB

Item Type:Horizon Scanning of Medicines
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
WB Practice of medicine > WB 300-962 Therapeutics
WF Respiratory system
Language:English
Series Name:Fact Sheet Nr. 190
Deposited on:24 Sep 2024 10:54
Last Modified:24 Sep 2024 10:54

Repository Staff Only: item control page